During the forecast period 2023 to 2033, the Oncolytic Adenovirus Market Demand is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Oncolytic Adenovirus is expected to rise up to a market valuation of US$ 250 Billion. Growth of the market can be attributed to increasing investments by key players for research and development of medication for Oncolytic Adenovirus.
Oncolytic Adenovirus is a promising approach in the field of cancer therapy. Adenoviruses are common viruses that can cause respiratory infections in humans, but they can also be genetically modified to specifically target and destroy cancer cells. These viruses are engineered to selectively replicate within tumor cells while sparing normal healthy cells. They are designed to infect cancer cells, replicate inside them, and ultimately cause their death. Oncolytic Adenoviruses can be injected directly into the tumor site or administered systemically, allowing them to reach tumors throughout the body.
Unlock growth potential with industry expertise. Download your market sample report now: https://www.futuremarketinsights.com/reports/sample/rep-gb-16235
One of the key advantages of Oncolytic Adenovirus therapy is its ability to not only directly kill cancer cells but also stimulate an immune response against the tumor. When the adenovirus replicates inside cancer cells, it releases viral particles and antigens that can activate the immune system. This immune response can help eliminate not only the infected tumor cells but also other cancer cells that may be present in the body. Additionally, Oncolytic Adenoviruses can be modified to carry therapeutic genes that can enhance the immune response or directly target specific signaling pathways involved in tumor growth and survival.
Key Takeaways from the Market Study
- The Oncolytic Adenovirus market is expected to possess 7.5% CAGR in the forecast period 2023 to 2033
- By application, lung cancer is expected to possess 35% market share for Oncolytic Adenovirus in 2023.
- North America is expected to possess 43% market share for Oncolytic Adenovirus market in 2023.
- Asia Pacific Oncolytic Adenovirus market size is expected to possess 39% market share in 2023.
“Growing prevalence of cancer amongst all age groups along with technological integration to create therapeutic medication is creating lucrative opportunities for Oncolytic Adenovirus market.” states a Future Market Insights analyst
Oncolytic Adenovirus Market Report Available At a Discounted Price: https://www.futuremarketinsights.com/request-discount/rep-gb-16235
Competitive Landscape
Key players in the Oncolytic Adenovirus market are Amgen, Sorrento Therapeutics, Transgene SA, Oncolys BioPharma, Targovax, Lokon Pharma, Vyriad, TILT Biotherapeutics, CG Oncology Inc, VCNBiosciences, DNAtrix, Replimune Group Inc
- Lokon Pharma AB is a Swedish biotech company developing the LOAd platform of Oncolytic Adenoviruses genetically engineered to express immunostimulatory genes in malignant tumors and tumor stroma.
- TILT Biotherapeutic’s head of R&D Riikka Havunen was awarded oral presentation “Oncolytic Adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable treatment of solid tumors with T cell therapies” at the 16th Cancer Immunotherapy Annual Meeting in Mainz, Germany in May 2018.
More Valuable Insights
Future Market Insights, in its new offering, presents an unbiased analysis of the global Oncolytic Adenovirus market, presenting historical analysis from 2017 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis of Type (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Others), Application (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Others), regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).
Customize Your Report Now: https://www.futuremarketinsights.com/customization-available/rep-gb-16235
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs